New Two-Pronged attack tested in aggressive lung cancer

NCT ID NCT06773910

Recruiting now Disease control Sponsor: SCRI Development Innovations, LLC Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a new two-drug immunotherapy combination (BMS-986489) works better than the current standard immunotherapy (durvalumab) for people with limited-stage small cell lung cancer. About 250 participants who have already completed initial chemotherapy and radiation will receive one of these treatments to try to keep the cancer from coming back. The main goal is to see if the new combination helps people live longer compared to the standard treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Baptist Health - Lexington
RECRUITING

Lexington, Kentucky, 40503, United States
Baptist Health - Louisville
RECRUITING

Louisville, Kentucky, 40207, United States
Blue Ridge Cancer Center (Oncology & Hematology Associates of Southwest VA)
RECRUITING

Salem, Virginia, 24153, United States
Cancer Care Centers of Brevard
RECRUITING

Palm Bay, Florida, 32901, United States
Florida Cancer Specialists - East
RECRUITING

West Palm Beach, Florida, 33401, United States
Florida Cancer Specialists - North
RECRUITING

Orange City, Florida, 32763, United States
Florida Cancer Specialists - South
RECRUITING

Fort Myers, Florida, 33901, United States
Illinois Cancer Care
RECRUITING

Peoria, Illinois, 61615, United States
Illinois Cancer Specialists
RECRUITING

Arlington Heights, Illinois, 60005, United States
Indiana University Simon Cancer Center
RECRUITING

Indianapolis, Indiana, 46202, United States
Mid Ohio Hem/ Onc dba The Mark H Zangmeister Center
RECRUITING

Columbus, Ohio, 43219, United States
Minnesota Oncology Hematology
RECRUITING

Maple Grove, Minnesota, 55369, United States
Missouri Cancer Associates
RECRUITING

Columbia, Missouri, 65201, United States
Ocala Oncology Center
RECRUITING

Ocala, Florida, 34474, United States
Oncology Associates of Oregon (Willamette Valley Cancer Institute and Research Center)
RECRUITING

Eugene, Oregon, 97401, United States
Oncology Hematology Care
RECRUITING

Cincinnati, Ohio, 45242, United States
SCRI Oncology Partners
RECRUITING

Nashville, Tennessee, 37203, United States
Sansum Clinic
RECRUITING

Santa Barbara, California, 93105, United States
Southern Cancer Center
RECRUITING

Daphne, Alabama, 36526, United States
Tennessee Cancer Specialists
RECRUITING

Knoxville, Tennessee, 37909, United States
Texas Oncology - DFW
RECRUITING

Dallas, Texas, 75246, United States
Texas Oncology - Gulf Coast
RECRUITING

Beaumont, Texas, 77702, United States
Texas Oncology - Northeast Texas
RECRUITING

Denison, Texas, 75020, United States
Texas Oncology - San Antonio
RECRUITING

San Antonio, Texas, 78240, United States
Texas Oncology - West Texas
RECRUITING

Amarillo, Texas, 79124, United States
Texas Oncology- Austin
RECRUITING

Austin, Texas, 78705, United States
University of Miami - Sylvester Cancer Center
ACTIVE_NOT_RECRUITING

Miami, Florida, 33136, United States
Virginia Cancer Specialists
RECRUITING

Fairfax, Virginia, 22031, United States
Virginia Oncology Associates
RECRUITING

Norfolk, Virginia, 23502, United States
White Plains Hospital Physician Associates
RECRUITING

White Plains, New York, 10601, United States

Conditions

Explore the condition pages connected to this study.

LIMITED STAGE SMALL CELL LUNG CANCER